Discover how TrueMed uses HSA/FSA funds to incentivize preventive healthcare. Learn about the chronic disease crisis and lifestyle interventions transforming...
How TrueMed Is Incentivizing Americans to Invest in Prevention
Key Takeaways
- America's health crisis is structural: Ultra-processed foods, sedentary lifestyles, and toxic chemicals have created an environment where chronic disease is the default outcome, not the exception
- Prevention is radically underfunded: While the U.S. spends hundreds of thousands treating diseases like heart disease, lifestyle interventions that could prevent them remain entirely out-of-pocket expenses
- TrueMed's tax-free solution: The platform allows Americans to use HSA/FSA funds for evidence-based lifestyle interventions like fitness, sleep optimization, and healthy nutrition
- Food system overhaul needed: Crop subsidies artificially cheapen processed ingredients, making unhealthy foods cheaper than nutritious alternatives—a deliberate economic structure, not a personal choice problem
- Environmental health equals personal health: Individual behavior change has limits; systemic environmental redesign toward health-promotion is the real solution
The Crop Subsidy Trap: How Government Policy Creates Artificial Incentives for Illness
The U.S. government has spent nearly $100 billion on crop subsidies over the last decade, primarily benefiting corn, soy, and wheat production. While these subsidies originally intended to help farmers survive bad weather and market volatility, they've created unintended catastrophic consequences for public health.
When crops are artificially cheap due to government subsidies, they become the most profitable ingredient for food manufacturers. Soybean oil costs almost nothing. High-fructose corn syrup costs almost nothing. Corn-fed beef costs less than grass-fed alternatives. Big food companies—many 150 years old and optimized purely for shareholder returns—naturally use these subsidized inputs in virtually every processed product. The result is a food system where the cheapest options are systematically the most toxic.
This is uniquely American. European countries, with smaller populations and more localized food systems, haven't created the same subsidy-driven infrastructure for chronic disease. The regulatory capture is also distinctly American: large corporations like Coca-Cola spend millions annually influencing FDA nutrition guidelines and funding industry-friendly research. The previous FDA commissioner's stated goal was "combating misinformation"; the current one aims to "make Americans healthy"—a revealing difference in priorities.
Consider the school lunch crisis: 80% of American schools have contracts with soda companies that place vending machines in exchange for funding. This means the institution responsible for children's nutrition is literally profiting from their consumption of sugary drinks that contribute directly to obesity and diabetes. It's a perverse incentive structure that would be unthinkable if framed as "we're going to poison children to fund their schools."
The solution isn't complicated: eliminating crop subsidies for unhealthy crops, reforming the FDA's GRAS (Generally Recognized as Safe) approval process for food additives to match European standards, and removing corporate influence from nutrition guidelines. But this requires political will to challenge one of agriculture's most entrenched lobbying structures.
The Limits of Pharmaceutical Solutions: Why Ozempic Isn't a Cure
The rise of GLP-1 receptor agonists like Ozempic represents a genuine breakthrough in appetite regulation. For a population where 80% are overweight, these medications work remarkably well and have generated enormous enthusiasm. But treating the symptom of overeating while ignoring the root cause—a food system engineered to be addictive and nutritionally deficient—is like treating pneumonia by suppressing cough without addressing the infection.
Here's the fundamental problem: if someone takes Ozempic and eats less, but still consumes ultra-processed food, they're eating less poison, not eating healthy. They'll develop severe deficiencies in protein, micronutrients, and essential compounds their body desperately needs. The long-term health outcomes would still be poor.
Furthermore, relying on a single pharmaceutical intervention has a terrible historical track record. We've tried this approach repeatedly—with antibiotics, with statins, with antidepressants—and learned that magic bullets don't exist when structural problems remain unsolved. A population eating less poison is still eating poison. The real solution requires fixing what goes into that food system.
That said, GLP-1s do have an important role: they can jumpstart people toward health by creating initial momentum. They reduce appetite, making it possible to break free from the addictive food cycle and establish better eating patterns. But they should be viewed as a temporary scaffold enabling behavioral change, not as a permanent solution to a food system problem.
The Consciousness Connection: Health as Energy, Presence, and Vitality
Beneath discussions of calories, macronutrients, and biomarkers lies a more fundamental question: what does it actually mean to be healthy? It's not merely the absence of disease. It's the presence of energy, clarity, excitement, and the capacity to engage fully with life. It's consciousness itself—the root layer of human experience.
When someone eats well, sleeps deeply, moves their body regularly, and avoids toxic chemicals, they don't just improve their biomarkers. They experience a profound shift in consciousness: more mental clarity, better emotional regulation, enhanced creativity, deeper presence in relationships, and greater capacity to pursue meaningful work. Conversely, the default American environment—processed food, sleep deprivation, sedentary work, constant digital stimulation—creates a consciousness of fatigue, mental fog, and subtle despair.
This biological-consciousness connection is massively underexplored. We've developed elaborate psychological theories about depression, anxiety, and mental illness without first asking: "Am I sleeping well? Am I eating well? Am I moving my body? Have I been outside recently? Am I exposed to sunlight? What toxins am I breathing?" These aren't psychological questions; they're environmental and biological questions.
Recent research in "metabolic psychiatry" suggests that many conditions traditionally categorized as mental health disorders—depression, schizophrenia, bipolar disorder, even epilepsy—have metabolic roots. Some individuals with schizophrenia experience complete symptom resolution on a ketogenic diet. Some people with treatment-resistant depression see dramatic improvement through functional medicine approaches emphasizing gut health, reduced inflammation, and metabolic optimization, often surpassing outcomes from years of talk therapy alone.
Yet we vastly underestimate this biological foundation of consciousness. Humans aren't minds in machines; we're biological organisms where mental health is intimately woven into physical health. The solution isn't deeper psychoanalysis. It's asking whether someone is optimizing the biological foundations that consciousness depends on.
TrueMed's Solution: Making Prevention Financially Rational
The current healthcare system creates an absurd incentive structure: prevention is unsubsidized, while disease treatment is fully covered. If someone is at risk of cardiovascular disease, they pay entirely out-of-pocket for gym memberships, nutrition coaching, and supplements. But if they have a heart attack, the healthcare system spends hundreds of thousands—often millions—managing their condition for the rest of their lives.
From a purely economic standpoint, this is insane. Preventing disease costs exponentially less than treating it. Yet because prevention falls outside the traditional drug-and-procedure model that insurance companies recognize as "healthcare," it remains invisible to the financial incentive structures that drive behavior.
TrueMed solves this by leveraging existing tax-advantaged accounts—Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs)—that millions of Americans already have access to. The company partners with lifestyle brands (Eight Sleep, Peloton, Lifetime Fitness, Momentous) to allow people to spend tax-free HSA/FSA dollars on evidence-based lifestyle interventions.
This accomplishes several things simultaneously:
It reframes lifestyle interventions as healthcare: When someone spends their HSA on a gym membership or sleep optimization device, they're not spending "personal money" on luxury wellness. They're treating their risk for heart disease with the same seriousness that their insurance treats treating an actual heart attack.
It creates powerful financial incentives: Tax-free money is real money. For someone considering whether to prioritize expensive supplements or a quality fitness program, tax-free spending can mean the difference between accessing these tools and not. This is particularly impactful for middle-class Americans who can benefit from these interventions but find them difficult to afford.
It builds infrastructure for scale: By integrating payment systems with lifestyle brands, TrueMed doesn't require inventing new products. It connects Americans with products and services that already effectively improve health—sleep optimization, fitness training, nutrition coaching, supplements—but removes the financial friction preventing access.
The vision extends further: eventually, every American with a chronic disease risk factor should be incentivized to spend available tax-free money on interventions that prevent, treat, or reverse disease. Someone with prediabetes could use HSA funds for nutrition coaching and continuous glucose monitoring. Someone with early cognitive decline could use HSA funds for exercise programs and sleep optimization tools. Someone with metabolic syndrome could use HSA funds for food delivery services focused on whole foods.
This transforms the entire economic calculation around prevention: instead of prevention being a personal luxury expense, it becomes a tax-advantaged healthcare investment.
The Peptide Revolution: A Class of Compounds Beyond Traditional Pharmaceuticals
Peptides represent a genuinely different category of therapeutic compounds—one that most pharmaceutical companies have overlooked because peptides can't be patented in the way traditional drugs can be.
The current pharmaceutical model optimizes for "don't die": statins to reduce heart attack risk, metformin to delay diabetes progression, SSRIs to manage depression. These are damage-control medications for people already on the disease trajectory. Peptides operate in a different domain: enhance energy, improve muscle mass, strengthen bone density, reduce inflammation, improve gut health, optimize sleep architecture. They're compounds of the "human enhancement" category rather than the "disease management" category.
Early evidence suggests peptides are remarkably effective. Ketamine-assisted therapy often outperforms SSRIs for treatment-resistant depression and PTSD. BPC-157 shows extraordinary potential for gut healing and inflammation reduction. TB-500 appears to accelerate recovery from injuries. Semorelin can restore growth hormone production in aging populations. Yet these compounds have received a fraction of the research funding that traditional pharmaceuticals command, primarily because pharmaceutical companies can't monopolize them through patent protection.
This creates an enormous opportunity: a class of compounds that genuinely improve quality of life, cost a fraction of patented pharmaceuticals, and work through different mechanisms than anything currently in widespread use. As more people experiment with peptides—informed by their own biomarkers and biofeedback—we'll likely see health outcomes that pharmaceutical companies haven't imagined because they haven't invested in researching them.
The disruption to pharma could be substantial. Why would someone take a statin that creates muscle loss and sexual dysfunction when they could optimize their cholesterol, inflammation, and metabolic health through lifestyle interventions and peptides? The question isn't whether peptides will be disruptive; it's how quickly the regulatory environment and research infrastructure will adapt to study them seriously.
Nutritional Science Revolution: From Food Industry Funding to N-of-1 Experimentation
Nutrition science, as currently practiced in America, may be the worst-funded major field in science. Large food companies outfund the NIH on nutrition research by 11-to-1, creating a system where most published nutrition studies are funded by the industry being studied.
This has produced contradictory dietary dogmas: low-fat diets are optimal, then high-fat diets are optimal. Carbohydrates are terrible, then certain carbohydrates are healthy. Sugar is poisonous, but the previous FDA food pyramid actually recommended sugar for children under two years old—an utterly misguided recommendation that contributed directly to childhood obesity.
The solution isn't waiting for better research (which won't emerge until funding sources change). It's empowering individuals to become their own researchers through N-of-1 experimentation: trying different dietary approaches, measuring results through biomarkers and wearable devices, and observing what actually produces energy, mental clarity, and improved health.
This is particularly interesting with contrarian approaches like the Ray Peat diet, which inverts decades of nutritional dogma. Peat advocates argue that metabolism should be maximized rather than minimized, that sugar (especially from fruits and honey) should be prioritized over seed oils, and that the goal should be maximum energy rather than caloric restriction. This directly opposes the Bryan Johnson longevity model emphasizing plant-based diets, caloric restriction, and metabolic downregulation.
The remarkable thing: people following the Peat approach report extraordinary results. Energy increases, body composition improves, biomarkers improve, subjective well-being increases. This suggests either that decades of nutritional dogma were fundamentally wrong, or that different dietary approaches work for different people and genetics.
The answer is probably: both. People should experiment. Try a Peat-style approach for 90 days and measure results. Try a plant-based approach and measure results. Use continuous glucose monitors, biomarker testing, wearable devices, and subjective experience to determine what actually works for your unique biology. This data-driven self-experimentation approach is far more powerful than waiting for nutritional science to become less corrupted by corporate funding.
The Community Health Model: Where Individual Health Meets Environmental Design
The most underexplored opportunity in health transformation lies not in optimizing individual health, but in optimizing community health. The principle is straightforward: an organism's health is determined by its environment. Zoo animals develop health problems—obesity, depression, self-harm—despite having no predators and unlimited food, simply because the environment is unnatural. Wild animals in their natural habitat remain naturally healthy.
Applied to humans: instead of asking "How do I optimize my individual health while existing in a fundamentally sickness-promoting environment?" ask "How do we redesign the environment so that health is the natural default?"
This suggests opportunities that barely exist today:
Health-oriented communities: Suburbs and towns deliberately designed around health—prioritizing walkable neighborhoods, community gardens, shared fitness spaces, and vendor networks focused on whole foods rather than processed options. These aren't luxury developments; they're demonstrations that different environments produce different health outcomes.
Community-based health insurance: Groups of people committed to lifestyle interventions—lower carb, high movement, stress reduction—could pool insurance risk with much lower premiums because their actual health outcomes would be radically better. This creates financial incentives for environmental design around health rather than around illness.
Food access cooperatives: Networks of people buying directly from farmers and sharing bulk purchases, dramatically reducing the cost of whole foods while creating community around shared health values. This solves the "cost" objection while building social structures that support rather than undermine health choices.
Movement communities: Neighborhoods where people exercise together, walk together, spend time outside together—making healthy behavior social default rather than individual burden.
The insight is profound: health is contagious. Living in an environment where most people are healthy, where movement is built into daily life, where food is whole and unprocessed, where sleep is prioritized, creates a context where individual health becomes easy. Conversely, living in an environment where most people are sedentary, where processed food is everywhere, where sleep is devalued, makes individual health impossibly difficult.
Real transformation requires thinking about health through the lens of community redesign, not individual optimization.
Addressing Corporate Capture: Why Policy Reform Matters
The health crisis isn't accidental; it's the predictable outcome of corporate capture of the regulatory agencies meant to protect public health. This operates through several mechanisms:
Funding influence: Major food and pharmaceutical companies fund nutrition research, medical education, and professional guidelines. This creates a subtle but systematic bias where outcomes favorable to these companies are published and promoted, while contradictory findings are sidelined.
Regulatory revolving door: FDA commissioners rotate between government and industry positions, creating alignment between agency decisions and corporate interests. A former FDA commissioner's stated goal of "combating misinformation" reveals the priority: protecting official narratives rather than optimizing public health.
Lobbying capture: Monsanto spent millions lobbying to insert riders into legislation that shield them from lawsuits regarding their products' health impacts, despite billions in damages awarded for illnesses caused by glyphosate exposure. This is just one example of how corporate lobbying prevents accountability for harmful products.
Chemical regulation disparity: The EU requires novel chemical compounds to prove safety before market approval. The U.S. operates under GRAS (Generally Recognized as Safe) standards that effectively allow tens of thousands of chemicals into products with minimal testing. This regulatory gap means American consumers are exposed to chemicals banned in Europe, contributing significantly to the chronic disease burden.
Fixing this requires:
- GRAS reform: Requiring premarket safety testing for novel chemicals, matching European standards
- Subsidy elimination: Removing artificial price supports for crops that fuel processed food production
- FDA independence: Structural reforms preventing corporate influence over regulatory decisions
- School/military nutrition standards: Using government buying power to shift food supply toward whole foods
- Transparency requirements: Forcing food companies to clearly label processed ingredients and their health impacts
These aren't radical demands. They're standard practice in countries with better health outcomes. America's regulatory capture isn't inevitable; it's a choice.
The Mental Health Revolution: Metabolism Before Psychology
America's mental health crisis—epidemic rates of depression, anxiety, and suicide—is typically addressed through psychological and pharmaceutical interventions: therapy, SSRIs, psychiatric hospitalization. Yet we massively underestimate how much mental health is determined by metabolic and biological factors.
Consider the biological foundations that consciousness depends on:
Sleep quality: Two weeks of poor sleep produces depressive symptoms indistinguishable from clinical depression. Yet sleep is treated as optional in modern culture rather than foundational to mental health.
Inflammation: Chronic inflammation from processed foods, seed oils, and stress creates a inflammatory cascade affecting brain function. Reducing inflammation through diet often produces faster antidepressant effects than medications.
Gut health: The gut-brain axis is scientifically established; unhealthy gut bacteria produce metabolic byproducts that directly impact mood, cognition, and emotional regulation. Healing the gut often resolves depression.
Metabolic stability: Blood sugar crashes, insulin resistance, and metabolic instability create mood swings, anxiety, and depressive episodes. Stabilizing metabolism through whole foods and appropriate carbohydrates often resolves these conditions.
Micronutrient status: Deficiencies in B vitamins, magnesium, zinc, and omega-3 fatty acids correlate with depression and anxiety. Supplementing these often produces remarkable mood improvements.
The field of "metabolic psychiatry"—exploring the metabolic roots of conditions like depression, bipolar disorder, schizophrenia, and epilepsy—remains dramatically underfunded despite emerging evidence that metabolic interventions often outperform psychiatric medications. Someone with treatment-resistant depression who underwent 10 years of talk therapy and tried six different psychiatric medications might experience complete symptom resolution through a functional medicine approach emphasizing sleep, gut health, reduced inflammation, and metabolic optimization.
This isn't to dismiss psychology or medications. It's to recognize that before pursuing deep psychoanalysis about why someone is depressed, the first question should be: "Are you sleeping well? Eating well? Moving your body? Getting outside? Managing stress? Free from blood sugar crashes? In a healthy inflammatory state?"
Reorienting mental healthcare toward these biological foundations would produce better outcomes, lower costs, and would address the true source of the mental health crisis.
Conclusion: Building the Health System America Actually Needs
America's health crisis is neither inevitable nor unsolvable. It results from deliberate policy choices—crop subsidies, regulatory capture, corporate influence over guidelines—that have been made and can be unmade.
The solutions exist: eliminate subsidies that cheapen processed foods, reform food regulations to match European standards, reorient the healthcare system toward prevention, leverage tax-advantaged funds to incentivize lifestyle interventions, fund research into peptides and metabolic psychiatry, and fundamentally redesign communities and food systems around health rather than profit.
TrueMed represents one crucial piece: making prevention financially rational by removing friction between people at risk of disease and the interventions that prevent it. But the larger transformation requires systemic change across agriculture, regulation, food systems, and healthcare incentives.
For individuals: use available tools to optimize your health—experiment with nutrition, prioritize sleep, move your body, connect with community, measure what actually works through biomarkers and biofeedback. For policymakers and entrepreneurs: recognize that genuine wealth cannot be created in a fundamentally unhealthy population, and that the highest-ROI investments are those that transform the environment that produces health as the default outcome.
The question isn't whether America can solve its health crisis. It's whether we'll prioritize population health over corporate profit. Everything else follows from that choice.
Original source: How Truemed Is Incentivizing Americans to Invest in Prevention
powered by osmu.app